Developer docs
API playgroundTry for free, no card

Search company profiles

Ideal Implant

Full company profile

uuid0004aek

Namestring
Ideal Implant
Legal namestring
Ideal Implant Inc.
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Ideal Implant Inc., founded in 2006 and headquartered in Plano, Texas, is a medical device company that developed, manufactured, and marketed a proprietary structured saline breast implant designed to deliver the natural look and feel of silicone with the safety profile of saline. Its core technology is a dual-lumen design comprising a smooth silicone inner shell and a smooth silicone outer shell, each filled with saline via separate valves, separated by one to three nested baffle shells perforated with slits that control saline movement and reinforce implant edges. The device received one of the few U.S. FDA Class III approvals for structured saline breast implants and demonstrated lower capsular contracture and deflation rates in a 10-year clinical study, supported by a Limited Lifetime Warranty.

The company generated revenue through direct hardware sales of breast implants to plastic and reconstructive surgery practices and hospitals, with go-to-market executed via enterprise field sales targeting board-certified plastic surgeons and supporting surgeon education, IFUs, sizing tools, and a device-tracking program. Following its August 2023 acquisition by Bimini Health Tech, Ideal Implant was rebranded as the Serene Breast Implant and integrated into a broader Bimini portfolio that now includes PureGraft fat grafting, Essence ADM acellular dermal matrix, Dermapose dermal tissue, Healeon PRP, and the Kerastem hair restoration pipeline product. The combined product set is manufactured under ISO 13485 and MDSAP quality systems and is distributed globally through Bimini's commercial operations.

Robert S. Hamas serves as President, CEO, and Founder of the legacy entity. Ideal Implant had raised approximately $7.56M across five known funding rounds between 2011 and 2018 prior to the Bimini transaction, and operated with 11–50 employees as a privately held subsidiary post-acquisition.

Short descriptiontext

Ideal Implant developed a proprietary dual-lumen structured saline breast implant offering silicone-like aesthetics with saline safety, FDA Class III approved. Acquired by Bimini Health Tech in 2023 and rebranded as Serene Breast Implant, serving plastic and reconstructive surgeons.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDallas, United States
HQ citystring
Dallas
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
structured breast implants, cosmetic surgery devices, plastic surgery implants, saline breast implants, reconstructive surgery products
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Breast Implants (Medical Devices)
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Breast Implant Sales
TypeHardware Sales
Description

Sale of structured saline breast implants to plastic and reconstructive surgery practices and hospitals worldwide through Bimini Health Tech's distribution network following the August 2023 acquisition.

openpr.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Technology or R&D, Marketing or Sales, Personnel
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Serene Breast Implant
Description

Structured saline breast implant with innovative design featuring a smooth silicone inner shell, smooth silicone outer shell, and internal baffle structure. Builds upon the foundation of the former Ideal Implant.

biminihealthtech.com
Core offering1 text field

Ideal Implant Inc. develops, manufactures, and markets structured saline-filled breast implants for cosmetic and reconstructive surgery. Following its August 2023 acquisition by Bimini Health Tech, the technology was rebranded as the Serene Breast Implant and continues to be sold to plastic and reconstructive surgeons worldwide through Bimini's distribution network. The flagship product features an innovative dual-lumen design with internal nested baffle shells that deliver the look and feel of silicone with the safety profile of saline.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Lower capsular contracture and deflation rates demonstrated in 10-year clinical study
Product overview1 text field

Ideal Implant, now part of Bimini Health Tech following an August 2023 acquisition, offers a portfolio of medical devices for plastic and reconstructive surgery. The flagship product is the Serene Structured Saline Breast Implant™ (the enhanced evolution of the former Ideal Implant), which features an innovative dual-lumen design with internal baffle shells for natural look and feel. The portfolio also includes PureGraft® fat grafting products, Essence ADM™ acellular dermal matrix, Dermapose® dermal products, Healeon® PRP products, and Kerastem™ in the pipeline. All products are designed to optimize outcomes in plastic and reconstructive surgery.

Product and service1 record
1Serene Breast Implant (formerly Ideal Implant)
CategoryBreast Implants (Medical Devices)
Description

A structured saline breast implant featuring an innovative dual-lumen design with an inner silicone shell and an outer silicone shell separated by nested internal baffle shells; it provides the look and feel of silicone with the safety profile of saline and is sold to plastic and reconstructive surgeons for breast augmentation, reconstruction, and revision procedures.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Sientra (now under Tiger Aesthetics/Mirum) sells silicone gel breast implants and was a U.S. challenger breast implant brand that similarly targeted safety and aesthetics differentiation. Directly comparable to Ideal Implant/Serene as a smaller U.S. breast implant specialist competing with Allergan and Mentor.

TypeDirect peer
Description

GC Aesthetics is a global breast implant and medical aesthetics manufacturer offering the Round and Anatomical collection plus the FixNip nipple-areola complex prosthesis. Closely comparable to Ideal Implant/Serene as an established independent breast implant specialist with international distribution.

3Silimed
TypeRegional player
Description

Silimed is a Brazilian manufacturer of silicone breast implants and other implantables with a strong Latin American and select international presence. Comparable to Ideal Implant/Serene as a competing breast implant specialist from outside the major incumbents, with regional rather than U.S.-centric distribution.

TypeOthers
Description

Bimini Health Tech is the parent company of Ideal Implant/Serene and a privately held commercial-stage medical device and biologics company. Included as an OTHERS peer because it represents the corporate owner/distributor rather than a direct product competitor, and offers adjacency to the same plastic and reconstructive surgery customer base.

TypeBroad incumbent
Description

Allergan Aesthetics (now AbbVie) is the other dominant breast implant manufacturer, offering Natrelle silicone gel and saline implants. Direct competition to Ideal Implant/Serene with the largest installed base and brand recognition in U.S. breast augmentation.

TypeRegional player
Description

Sebbin is a French manufacturer of silicone gel breast implants primarily distributed across Europe and select international markets. Comparable to Ideal Implant/Serene as a competing breast implant specialist, though Sebbin's footprint is more Europe-centric compared to the U.S.-anchored Serene product.

TypeDirect peer
Description

POLYTECH Health & Aesthetics is a German breast implant manufacturer offering silicone gel and polyurethane-coated implants used globally in aesthetic and reconstructive surgery. Comparable to Ideal Implant/Serene as a specialty breast implant manufacturer competing for share outside the Allergan/Mentor duopoly.

8Mentor (Johnson & Johnson)
TypeBroad incumbent
Description

Mentor is one of the two dominant U.S. breast implant manufacturers, part of Johnson & Johnson MedTech, offering the MemoryGel and CPG saline implants. Comparable to Ideal Implant/Serene as a competing breast implant franchise with much broader portfolio, sales force, and surgeon relationships.

TypeDirect peer
Description

Establishment Labs markets the Motiva Ergonomix and Motiva Flora breast implant lines, including smoothSilk and SilkSurface technologies, and is the most direct contemporary challenger to the legacy breast implant duopoly. Comparable to Ideal Implant/Serene as a differentiated, clinically-invested breast implant manufacturer pursuing share against Allergan and Mentor.

TypeRegional player
Description

HansBiomed is a Korean medical device company marketing cohesive gel and micro-textured breast implants primarily across Asia and select international markets. Comparable as an emerging breast implant specialist outside the dominant U.S. incumbents, with regional focus differing from Serene's U.S. anchor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ideal Implant

Breast Implants (Medical Devices)idealimplant.com

Ideal Implant developed a proprietary dual-lumen structured saline breast implant offering silicone-like aesthetics with saline safety, FDA Class III approved. Acquired by Bimini Health Tech in 2023 and rebranded as Serene Breast Implant, serving plastic and reconstructive surgeons.

What Ideal Implant does

Ideal Implant Inc., founded in 2006 and headquartered in Plano, Texas, is a medical device company that developed, manufactured, and marketed a proprietary structured saline breast implant designed to deliver the natural look and feel of silicone with the safety profile of saline. Its core technology is a dual-lumen design comprising a smooth silicone inner shell and a smooth silicone outer shell, each filled with saline via separate valves, separated by one to three nested baffle shells perforated with slits that control saline movement and reinforce implant edges. The device received one of the few U.S. FDA Class III approvals for structured saline breast implants and demonstrated lower capsular contracture and deflation rates in a 10-year clinical study, supported by a Limited Lifetime Warranty.

The company generated revenue through direct hardware sales of breast implants to plastic and reconstructive surgery practices and hospitals, with go-to-market executed via enterprise field sales targeting board-certified plastic surgeons and supporting surgeon education, IFUs, sizing tools, and a device-tracking program. Following its August 2023 acquisition by Bimini Health Tech, Ideal Implant was rebranded as the Serene Breast Implant and integrated into a broader Bimini portfolio that now includes PureGraft fat grafting, Essence ADM acellular dermal matrix, Dermapose dermal tissue, Healeon PRP, and the Kerastem hair restoration pipeline product. The combined product set is manufactured under ISO 13485 and MDSAP quality systems and is distributed globally through Bimini's commercial operations.

Robert S. Hamas serves as President, CEO, and Founder of the legacy entity. Ideal Implant had raised approximately $7.56M across five known funding rounds between 2011 and 2018 prior to the Bimini transaction, and operated with 11–50 employees as a privately held subsidiary post-acquisition.

Ideal Implant firmographics

Firmographics
Name
Ideal Implant
Legal name
Ideal Implant Inc.
Website
https://idealimplant.com
Company type
Private
Founded year
2006
Operating status
Acquired
Headcount range
11–50 employees
Short description
Ideal Implant developed a proprietary dual-lumen structured saline breast implant offering silicone-like aesthetics with saline safety, FDA Class III approved. Acquired by Bimini Health Tech in 2023 and rebranded as Serene Breast Implant, serving plastic and reconstructive surgeons.
Ownership category
akta.pro rank

Where Ideal Implant is headquartered

Location

Headquarters

HQ city
Dallas
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Ideal Implant business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Marketing or Sales, Personnel

Revenue model

  1. Breast Implant Sales: Sale of structured saline breast implants to plastic and reconstructive surgery practices and hospitals worldwide through Bimini Health Tech's distribution network following the August 2023 acquisition.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Ideal Implant product offering

Product offering

Core offering

Ideal Implant Inc. develops, manufactures, and markets structured saline-filled breast implants for cosmetic and reconstructive surgery. Following its August 2023 acquisition by Bimini Health Tech, the technology was rebranded as the Serene Breast Implant and continues to be sold to plastic and reconstructive surgeons worldwide through Bimini's distribution network. The flagship product features an innovative dual-lumen design with internal nested baffle shells that deliver the look and feel of silicone with the safety profile of saline.

Product overview

Ideal Implant, now part of Bimini Health Tech following an August 2023 acquisition, offers a portfolio of medical devices for plastic and reconstructive surgery. The flagship product is the Serene Structured Saline Breast Implant™ (the enhanced evolution of the former Ideal Implant), which features an innovative dual-lumen design with internal baffle shells for natural look and feel. The portfolio also includes PureGraft® fat grafting products, Essence ADM™ acellular dermal matrix, Dermapose® dermal products, Healeon® PRP products, and Kerastem™ in the pipeline. All products are designed to optimize outcomes in plastic and reconstructive surgery.

Differentiator

Problem solved

Functional benefit

Brands

  • Serene Breast Implant: Structured saline breast implant with innovative design featuring a smooth silicone inner shell, smooth silicone outer shell, and internal baffle structure. Builds upon the foundation of the former Ideal Implant.

Products and services

  • Serene Breast Implant (formerly Ideal Implant) A structured saline breast implant featuring an innovative dual-lumen design with an inner silicone shell and an outer silicone shell separated by nested internal baffle shells; it provides the look and feel of silicone with the safety profile of saline and is sold to plastic and reconstructive surgeons for breast augmentation, reconstruction, and revision procedures.

Quantifiable outcome

  • Lower capsular contracture and deflation rates demonstrated in 10-year clinical study

Companies that use Ideal Implant

Customer profile

Segments1 record

Ideal customer profiles1 record

Ideal Implant technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Ideal Implant partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Ideal Implant competitors and assessment

Company assessment

Direct peers

  • Sientra: Sientra (now under Tiger Aesthetics/Mirum) sells silicone gel breast implants and was a U.S. challenger breast implant brand that similarly targeted safety and aesthetics differentiation. Directly comparable to Ideal Implant/Serene as a smaller U.S. breast implant specialist competing with Allergan and Mentor.
  • GC Aesthetics: GC Aesthetics is a global breast implant and medical aesthetics manufacturer offering the Round and Anatomical collection plus the FixNip nipple-areola complex prosthesis. Closely comparable to Ideal Implant/Serene as an established independent breast implant specialist with international distribution.
  • POLYTECH Health & Aesthetics: POLYTECH Health & Aesthetics is a German breast implant manufacturer offering silicone gel and polyurethane-coated implants used globally in aesthetic and reconstructive surgery. Comparable to Ideal Implant/Serene as a specialty breast implant manufacturer competing for share outside the Allergan/Mentor duopoly.
  • Establishment Labs (Motiva): Establishment Labs markets the Motiva Ergonomix and Motiva Flora breast implant lines, including smoothSilk and SilkSurface technologies, and is the most direct contemporary challenger to the legacy breast implant duopoly. Comparable to Ideal Implant/Serene as a differentiated, clinically-invested breast implant manufacturer pursuing share against Allergan and Mentor.

Regional players

  • Silimed: Silimed is a Brazilian manufacturer of silicone breast implants and other implantables with a strong Latin American and select international presence. Comparable to Ideal Implant/Serene as a competing breast implant specialist from outside the major incumbents, with regional rather than U.S.-centric distribution.
  • Sebbin: Sebbin is a French manufacturer of silicone gel breast implants primarily distributed across Europe and select international markets. Comparable to Ideal Implant/Serene as a competing breast implant specialist, though Sebbin's footprint is more Europe-centric compared to the U.S.-anchored Serene product.
  • HansBiomed: HansBiomed is a Korean medical device company marketing cohesive gel and micro-textured breast implants primarily across Asia and select international markets. Comparable as an emerging breast implant specialist outside the dominant U.S. incumbents, with regional focus differing from Serene's U.S. anchor.

Others

  • Bimini Health Tech: Bimini Health Tech is the parent company of Ideal Implant/Serene and a privately held commercial-stage medical device and biologics company. Included as an OTHERS peer because it represents the corporate owner/distributor rather than a direct product competitor, and offers adjacency to the same plastic and reconstructive surgery customer base.

Broad incumbents

  • Allergan Aesthetics (AbbVie): Allergan Aesthetics (now AbbVie) is the other dominant breast implant manufacturer, offering Natrelle silicone gel and saline implants. Direct competition to Ideal Implant/Serene with the largest installed base and brand recognition in U.S. breast augmentation.
  • Mentor (Johnson & Johnson): Mentor is one of the two dominant U.S. breast implant manufacturers, part of Johnson & Johnson MedTech, offering the MemoryGel and CPG saline implants. Comparable to Ideal Implant/Serene as a competing breast implant franchise with much broader portfolio, sales force, and surgeon relationships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Ideal Implant social profiles

Digital presence

Ideal Implant compliance and trust

Trust signal

Compliance3 records

Ideal Implant financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ideal Implant leadership team

Management profile

Number of profiles

Profiles1 record

Ideal Implant funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ideal Implant M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ideal Implant

What does Ideal Implant do?

Ideal Implant Inc. develops, manufactures, and markets structured saline-filled breast implants for cosmetic and reconstructive surgery. Following its August 2023 acquisition by Bimini Health Tech, the technology was rebranded as the Serene Breast Implant and continues to be sold to plastic and reconstructive surgeons worldwide through Bimini's distribution network. The flagship product features an innovative dual-lumen design with internal nested baffle shells that deliver the look and feel of silicone with the safety profile of saline.

Is Ideal Implant a public or private company?

Ideal Implant is a private company. It is classified as corporate owned and is currently acquired.

When was Ideal Implant founded?

Ideal Implant was founded in 2006. It employs 11 to 50 people.

Where is Ideal Implant based?

Ideal Implant is headquartered in Dallas, United States, in the North America region.

How does Ideal Implant make money?

One revenue line is on record: breast Implant Sales.

Who are Ideal Implant's main competitors?

Direct peers on record are Sientra, GC Aesthetics, POLYTECH Health & Aesthetics and Establishment Labs (Motiva). Regional players are Silimed, Sebbin and HansBiomed. Bimini Health Tech is listed as an others. Broad incumbents are Allergan Aesthetics (AbbVie) and Mentor (Johnson & Johnson).

Does Ideal Implant have an API?

No public API is recorded for Ideal Implant.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comAnalysis of Key Market Segments Influencing the Cosmetic Implants IndustryThe cosmetic implants market is forecast to reach $17.56 billion by 2030, growing at a 7.3% CAGR, driven by rising demand for cosmetic procedures, medical tourism expansion, and innovations in bioengineered implant materials. In August 2023, Bimini Health Tech acquired Ideal Implants Inc., a US-based manufacturer of cosmetic implants including breast implants, to broaden its portfolio in plastic and reconstructive surgery globally. In July 2024, GC Aesthetics, a France-based manufacturer, introduced its Luna XT and PERLE breast implant products in Hainan, China, featuring advanced microtextured surfaces and bioengineered dynamic gel technology.PR NewswireFDA Strengthens Safety Requirements and Updates Study Results for Breast ImplantsThe U.S. Food and Drug Administration issued orders restricting the sale and distribution of breast implants and approved new mandatory labeling for all legally marketed breast implants, including a boxed warning, patient decision checklist, updated rupture screening recommendations, and materials disclosure. Manufacturers of seven breast implant products—IDEAL IMPLANT, Mentor, Allergan, and Sientra—must implement the updated labeling within 30 days. The FDA also released updated post-approval study data as part of its ongoing effort to improve transparency around breast implant risks and patient safety.PrwebIdeal Implant CEO Featured at IMCAS Innovation Shark Tank 2020Ideal Implant CEO Robert S Hamas presented the IDEAL IMPLANT breast implant at IMCAS Innovation Shark Tank 2020 in Paris. The implant's eight-year trial showed lower rupture and capsular contracture rates than silicone gel, and the company is expanding production to meet demand.PrwebIdeal Implant CEO Briefs North American Investors On New Advancements In Breast Implant TechnologyIdeal Implant CEO Robert S Hamas presented new breast implant technology at two North American investor forums in 2019-2020. The IDEAL IMPLANT Structured Breast Implant uses saline with a novel internal structure, claiming lower rupture and capsular contracture rates than silicone gel implants. The company plans to expand manufacturing capacity to meet growing demand.PrwebSilent Risk: Women “Constantly Concerned” About Silicone Breast Implant Ruptures—Expert Says Patient Anxiety Underestimated Because 90 Percent of Surgeons are MaleA survey of 1,143 women found 73% would be very or constantly concerned about silent silicone implant ruptures, with 97% wanting to know if rupture occurred and 95% wanting replacement even without symptoms. Surgeons, especially men, may underestimate this anxiety because 90% are male, and new structured saline implants like IDEAL IMPLANT offer lower rupture risk.PR Newswire6-Year Data on IDEAL IMPLANT Presented at the Annual Meeting of the American Society of Plastic Surgery in Orlando, FLIdeal Implant Incorporated announced new 6-year clinical trial data on the IDEAL IMPLANT Structured Breast Implant will be presented at the American Society of Plastic Surgeons annual meeting in Orlando, Florida on October 8, 2017. The data shows 90–94% patient and surgeon satisfaction rates, with low complication rates including 1.8% rupture and 5.7% capsule contracture over six years among 438 women. The presentations will be delivered by Dr. Gregg Anigian and Dr. Robert S. Hamas, the plastic surgeon and inventor who founded the company in 2006.PR NewswirePaul Herchman, Co-Founder of Thermi, Joins Board of Ideal ImplantIdeal Implant Incorporated announced the appointment of Paul Herchman, Co-Founder and former CEO of ThermiGen, to its Board of Directors, where he will also serve as a consultant in Corporate Development. The company simultaneously promoted National Sales Director Gabe Walters to Vice President of U.S. Sales while Kevin Morano transitioned from Board member to Chief Financial Officer. Herchman, who previously led the $82 million sale of ThermiGen to Almirall, S.A., stated he aims to expand the IDEAL IMPLANT's market reach through partnerships, marketing, and physician office expansion.